Erythromycin Stragen 1 g Pulver till infusionsvätska, lösning

Country: সুইডেন

ভাষা: সুইডিশ

সূত্র: Läkemedelsverket (Medical Products Agency)

সক্রিয় উপাদান:

erytromycinlaktobionat

থেকে পাওয়া:

Stragen Nordic A/S

এটিসি কোড:

J01FA01

INN (International Name):

erythromycin

ডোজ:

1 g

ফার্মাসিউটিকাল ফর্ম:

Pulver till infusionsvätska, lösning

রচনা:

erytromycinlaktobionat 1,49 g Aktiv substans

প্রেসক্রিপশন টাইপ:

Receptbelagt

অনুমোদন অবস্থা:

Avregistrerad

অনুমোদন তারিখ:

2015-12-10

তথ্য লিফলেট

_SE/H/1486/001_
1
06805
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
ERYTHROMYCIN STRAGEN 1 G POWDER FOR SOLUTION FOR INFUSION
erythromycin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or nurse.
-
If you get any side effects, talk to your doctor or nurse. This
includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Erythromycin Stragen is and what it is used for
2.
What you need to know before you use Erythromycin Stragen
3.
How to use Erythromycin Stragen
4.
Possible side effects
5.
How to store Erythromycin Stragen
6.
Contents of the pack and other information
1.
WHAT ERYTHROMYCIN STRAGEN IS AND WHAT IT IS USED FOR
Erythromycin Stragen is a powder for solution for infusion.
Erythromycin lactobionate, the active
substance of this medicine, belongs to the group of antibacterial
substances for systemic use (suitable
for intravenous injection).
Erythromycin Stragen disrupts the production of proteins by bacteria,
and thereby prevents the bacteria
from multiplying.
Erythromycin Stragen is used primarily for various bacterial
infections of the airways such as
pneumonia, whooping cough and diphtheria. Erythromycin Stragen is also
used for vaginal infections
and for eye inflammation and pneumonia in new-born infants caused by
_Chlamydia_
bacteria.
Erythromycin Stragen is also used in the treatment of pneumonia,
infections of the skin and soft
tissues in people who are intolerant to penicillin or where penicillin
is unsuitable for some other
reason.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE ERYTHROMYCIN STRAGEN
DO NOT USE ERYTHROMYCIN STRAGEN:
-
if you are allergic to erythromycin;
-
if you are allergic to any other of antibiotics from the same group
such as clarithomycin or
azithromycin;
-
if you have certain heart disorders (long QT syndrome, or acquired QT
prolongation).
-
if you are ta

পণ্য বৈশিষ্ট্য

_SE/H/1486/001_
06805
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF MEDICINAL PRODUCT
Erythromycin Stragen 1 g powder for solution for infusion
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 vial contains erythromycin lactobionate equivalent to 1g
erythromycin.
3.
PHARMACEUTICAL FORM
Powder for solution for infusion
White to slightly yellow powder.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Pneumonia caused by
_Legionella_
,
_Mycoplasma pneumoniae_
,
_Chlamydia psittaci_
(ornithosis) or
_Chlamydia pneumoniae_
(TWAR). Pertussis. Diphtheria. Urogenital infections caused by
_Chlamydia _
_trachomatis_
. Conjunctivitis and pneumonia in newborns caused by
_Chlamydia trachomatis_
.
Given the following indications, Erythromycin Stragen should be
reserved for patients who are
hypersensitive to penicillin or where penicillin is unsuitable for
other reasons: nosocomial pneumonia;
skin and soft tissue infections.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Posology_
_Adults and children over 12years old or weighing more than 40 kg_
:
15

20 mg/kg/day. Where necessary the dose may be increased to 4 g/day.
May be given in divided
doses every 6 or 8 hours (intermittent intravenous infusion) or as a
continuous intravenous infusion.
_Use in children up to 12 years old or weighing up to 40 kg_
_1 month to up to 12 years old:_
The daily dose for infants and children up to 12 years old for most
infections is 15-20 mg of
erythromycin/kg of body weight divided over 3-4 single doses. This
dose may be doubled depending
on the indication.
_Use in term newborn infants (birth to 1 month)_
10-15 mg/kg/day divided over 3 singles doses.
_Elderly:_
No special dose recommendations.
_Method of administration_
Because rapid infusion is closely associated with arrhythmias or
hypotension it is recommended that
Erythromycin Stragen should be administered slowly. This should be
particularly noted in patients
with risk factors or previous signs of arrhythmias.
A low infusion rate is also recommended for patients with heart
disease and for pr